Helus Pharma Inc. SEC filings HELP
Helus Pharma Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 20, 2020. Its latest annual report, Form 40-F, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Sep 1, 2026 | — |
| D | Filing | Aug 19, 2026 | — |
| D | Filing | Aug 19, 2026 | — |
| D | Filing | Jul 16, 2026 | — |
| D | Filing | Jul 16, 2026 | — |
| SUPPL | Form suppl | Jun 25, 2026 | — |
| D | Filing | Mar 23, 2026 | — |
| D | Filing | Jan 12, 2026 | — |
| CERT | Filing | Jan 2, 2026 | — |
| 8-A12B | Form 8-a12b | Jan 2, 2026 | — |
| 25 | Notification of removal from listing | Jan 2, 2026 | — |
| SUPPL | Form suppl | Dec 30, 2025 | — |
| D | Filing | Nov 26, 2025 | — |
| SUPPL | Form suppl | Oct 29, 2025 | — |
| D | Filing | Oct 15, 2025 | — |
| D | Filing | Sep 23, 2025 | — |
| SUPPL | Form suppl | Sep 18, 2025 | — |
| SUPPL | Form suppl | Sep 18, 2025 | — |
| SUPPL | Form suppl | Sep 17, 2025 | — |
| SUPPL | Form suppl | Sep 17, 2025 | — |
| D | Filing | Aug 27, 2025 | — |
| D | Filing | Aug 27, 2025 | — |
| SUPPL | Form suppl | Jul 14, 2025 | — |
| D | Filing | Jul 10, 2025 | — |
| SUPPL | Form suppl | Feb 11, 2025 | — |
| EFFECT | Filing | Jan 14, 2025 | — |
| D | Filing | Dec 10, 2024 | — |
| D | Filing | Sep 9, 2024 | — |
| D | Filing | Apr 22, 2024 | — |
| SUPPL | Form suppl | Apr 18, 2024 | — |
| D | Filing | Apr 3, 2024 | — |
| EFFECT | Filing | Jan 3, 2024 | — |
| D | Filing | Nov 29, 2023 | — |
| SUPPL | Form suppl | Nov 13, 2023 | — |
| SUPPL | Form suppl | Aug 24, 2023 | — |
| SUPPL | Form suppl | Aug 24, 2023 | — |
| SUPPL | Form suppl | Aug 18, 2023 | — |
| SUPPL | Form suppl | Aug 4, 2023 | — |
| SUPPL | Form suppl | Aug 2, 2023 | — |
| SUPPL | Form suppl | Aug 1, 2023 | — |
| D | Filing | Jul 10, 2023 | — |
| SUPPL | Form suppl | May 31, 2023 | — |
| SUPPL | Form suppl | Aug 8, 2022 | — |
| D | Filing | Apr 28, 2022 | — |
| D | Filing | Apr 28, 2022 | — |
| D | Filing | Mar 22, 2022 | — |
| D | Filing | Mar 21, 2022 | — |
| EFFECT | Filing | Oct 8, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| SEC STAFF ACTION | Filing | Jul 30, 2021 | — |
| CERT | Nyse american certification | Jul 29, 2021 | — |
| 40FR12B | Filing | Jul 26, 2021 | — |
| D | Filing | Nov 20, 2020 | — |
| D | Filing | Nov 20, 2020 | — |
| D | Filing | Nov 20, 2020 | — |
| D | Filing | Nov 20, 2020 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HELP (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833141
- Former names
- CYBIN INC. (until Sep 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.